Elevance Health trades at $423.06 per share and has stayed right on track with the overall market, losing 14% over the last six months while the S&P 500 is down 14.2%. This was partly driven by its ...

Indianapolis-based health Elevance Health’s board is recommending its investors reject a shareholder proposal that asks the ...

Let’s take a look at how Elevance Health (NYSE:ELV) and the rest of the health insurance providers stocks fared in Q4. Upfront premiums collected by health insurers lead to reliable revenue ...

We believe that the Blue Cross Blue Shield brand is the most recognizable and trusted franchise in the US health insurance industry. As the largest Blue Cross Blue Shield operator, Elevance only ...

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $477.08, along with a high estimate of $512.00 and a low estimate of $405.40. Marking an ...

Elevance Health (ELV) stock is one of the worst S&P 500 stocks in Thursday's session. The selloff comes after the health insurance company missed bottom-line expectations for its third quarter and ...

These firms often struggle for an extended period of time before becoming profitable, but when they see success with a new MarketBeat Health Insurance ETFs in Focus as RFK Jr Takes Over HHS Robert F.

A virtuous cycle can ensue if a scaled company plays its cards ... Elevance Health is one of the most scaled enterprises in healthcare. This is particularly important because health insurance ...

Elevance Health (NYSE:ELV) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. In the table below, you'll find a summary of ...